JP7834343B2 - イオン性化学種濃縮方法 - Google Patents

イオン性化学種濃縮方法

Info

Publication number
JP7834343B2
JP7834343B2 JP2022519948A JP2022519948A JP7834343B2 JP 7834343 B2 JP7834343 B2 JP 7834343B2 JP 2022519948 A JP2022519948 A JP 2022519948A JP 2022519948 A JP2022519948 A JP 2022519948A JP 7834343 B2 JP7834343 B2 JP 7834343B2
Authority
JP
Japan
Prior art keywords
derivatives
chemical species
cation
ionic chemical
anion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022519948A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021225113A5 (https=
JPWO2021225113A1 (https=
Inventor
裕美 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto Institute of Technology NUC
Original Assignee
Kyoto Institute of Technology NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Institute of Technology NUC filed Critical Kyoto Institute of Technology NUC
Publication of JPWO2021225113A1 publication Critical patent/JPWO2021225113A1/ja
Publication of JPWO2021225113A5 publication Critical patent/JPWO2021225113A5/ja
Application granted granted Critical
Publication of JP7834343B2 publication Critical patent/JP7834343B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
JP2022519948A 2020-05-08 2021-04-30 イオン性化学種濃縮方法 Active JP7834343B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020082512 2020-05-08
JP2020082512 2020-05-08
PCT/JP2021/017165 WO2021225113A1 (ja) 2020-05-08 2021-04-30 イオン性化学種濃縮方法

Publications (3)

Publication Number Publication Date
JPWO2021225113A1 JPWO2021225113A1 (https=) 2021-11-11
JPWO2021225113A5 JPWO2021225113A5 (https=) 2024-04-04
JP7834343B2 true JP7834343B2 (ja) 2026-03-24

Family

ID=78468094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022519948A Active JP7834343B2 (ja) 2020-05-08 2021-04-30 イオン性化学種濃縮方法

Country Status (2)

Country Link
JP (1) JP7834343B2 (https=)
WO (1) WO2021225113A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025030598A (ja) * 2023-08-24 2025-03-07 国立大学法人京都工芸繊維大学 イオン性化学種濃縮方法および脂質粒子

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018530623A (ja) 2015-10-15 2018-10-18 リポメディックス・ファーマシューティカルズ・リミテッドＬｉｐｏｍｅｄｉｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． ドキソルビシンおよびマイトマイシンｃプロドラッグを共封入したリポソーム組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06511470A (ja) * 1991-07-03 1994-12-22 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド 薬剤を含むリポソームの調製における充填技術

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018530623A (ja) 2015-10-15 2018-10-18 リポメディックス・ファーマシューティカルズ・リミテッドＬｉｐｏｍｅｄｉｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． ドキソルビシンおよびマイトマイシンｃプロドラッグを共封入したリポソーム組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MURAKAMI, Koji et al.，Distribution and Adsorption of Ionic Species into a Liposome Membrane and Their Dependence upon the，LANGMUIR，2016年09月29日，Vol.32，p.10678-10684，DOI:10.1021/acs.langmuir.6b03162
OMATSU, Terumasa et al.，Dynamic behavior analysis of ion transport through a bilayer lipid membrane by an electrochemical me，Analyst，2020年03月27日，Vol.145，p.3839-3845，DOI:10.1039/d0an00222d
村上宏司 ほか，脂質二分子膜に対するイオンの吸着と分配，BUNSEKI KAGAKU，2018年，Vol.67, No.10，p.581-588

Also Published As

Publication number Publication date
WO2021225113A1 (ja) 2021-11-11
JPWO2021225113A1 (https=) 2021-11-11

Similar Documents

Publication Publication Date Title
Maestrelli et al. New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics
Abraham et al. The liposomal formulation of doxorubicin
de Paula et al. Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure
JP7834343B2 (ja) イオン性化学種濃縮方法
Cortez et al. Highly-organized stacked multilayers via layer-by-layer assembly of lipid-like surfactants and polyelectrolytes. Stratified supramolecular structures for (bio) electrochemical nanoarchitectonics
RU2018115715A (ru) Стабилизирующие фармацевтические композиции камптотецина
JP2018530563A5 (https=)
CN1361681A (zh) 脂质包埋的治疗剂的制备方法
US9873669B2 (en) Cationic lipid
US20110150984A1 (en) Methods of increasing the bioavailability and/or cellular update of drugs
US20190374647A1 (en) Stable liposomes for drug delivery
Suwalsky et al. Interactions of the antiviral and antiparkinson agent amantadine with lipid membranes and human erythrocytes
D Mishra et al. Formulation and optimization of ethosomes for transdermal delivery of ropinirole hydrochloride
Trementozzi et al. Liposome-mediated chemotherapeutic delivery is synergistically enhanced by ternary lipid compositions and cationic lipids
Rinaldi et al. Decoration of nanovesicles with pH (low) insertion peptide (pHLIP) for targeted delivery
WO2007049278A2 (en) A method for preparing liposomes and uses thereof
CN115417780B (zh) 可离子化的阳离子脂c5-a2及由其组成的纳米脂质体颗粒
JP2025030598A (ja) イオン性化学種濃縮方法および脂質粒子
CN103181897A (zh) 吉非替尼脂质体制剂及其制备方法
CZ131799A3 (cs) Nosič založený na lipidu zahrnující lamelární lipidový komponent a jeho terapeutické využití
Odette et al. EDTA-gradient loading of doxorubicin into ferrocene-containing liposomes: effect of lipid composition and visualization of triggered release by Cryo-TEM
CN115417778A (zh) 可离子化的阳离子脂c5及由其组成的纳米脂质体颗粒
JP7406207B2 (ja) 脂質ドメイン形成基板及び脂質ドメイン形成方法
WO2020175281A1 (ja) バイセル及びその利用
Seimiya et al. Effects of composition and molecular packing on ionic properties of lipid monolayer having both cationic and anionic head groups

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250526

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250819

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251118

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260304

R150 Certificate of patent or registration of utility model

Ref document number: 7834343

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150